3Granger,CB,Califf RM,Topol EJ.Thrombolytic therapy for acute myocardial infarction.A review[J].Drugs,1992,44:293 -325.
4Califf,RM,Fortin DF,Tenaglia,AN,et al.Clinical risks of thrombolytic therapy[J].Am J Cardiol,1992,69:12A-20A.
5Sane DC,Califf RM,Topol EJ,et al.Bleeding during thrombolytic therapy for acute myocardial infarction:mechanisms and management[J].Ann Intern Med,1989,111:1010-1022.
6Willerson JT.Conversion from chronic to acute coronary heart disease syndromes.Role of platelets and platelet products[J].J Tex Heart Inst,1995,22:13-19
7Willerson JT,Golino P,Eidt J,et al.Specific platelet mediators and unstable coronary artery lesions.Experimental eviolence and potence and potential clinical implications[J].Circulation,1989,80:198-205.
